Related Experiment Video
Updated: Aug 11, 2026

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats
Published on: May 22, 2019
Heart diseases and stroke
1Cerebrovascular Center, Section of Stroke and Neurologic Intensive Care, Cleveland Clinic, 9500 Euclid Avenue S-91, Cleveland, OH 44195, USA. silac@ccf.org
Insights
Heart diseases cause embolic events, with atrial fibrillation common in older adults and patent foramen ovale in younger individuals. Treatment involves managing heart conditions and preventing embolism, though balancing anticoagulant therapy risks and benefits is challenging.
Area of Science:
- Cardiology
- Neurology
- Vascular Medicine
Background:
- A diverse range of cardiac conditions contribute to embolic phenomena, leading to both cerebral and systemic embolisms.
- Atrial fibrillation is a primary cause of cardioembolic stroke, especially in the elderly population.
- Congenital heart defects, like patent foramen ovale, are significant contributors to embolism in younger individuals.
Purpose of the Study:
- To review the causes and therapeutic strategies for cardioembolic events.
- To highlight the role of atrial fibrillation and patent foramen ovale in embolic stroke.
- To discuss the challenges and advancements in managing cardioembolic disease.
Main Methods:
- Literature review of heterogeneous heart diseases causing embolism.
- Analysis of etiological factors including atrial fibrillation and patent foramen ovale.
- Evaluation of current and emerging therapeutic approaches for embolism prevention.
Main Results:
- Cardioembolic events stem from varied cardiac pathologies affecting anatomy and physiology.
- Atrial fibrillation represents a major source of cardioembolic stroke, predominantly in the elderly.
- Patent foramen ovale is a key factor in embolic events among younger populations.
Conclusions:
- Effective management requires addressing underlying cardiac disease and implementing embolism prevention strategies.
- Oral anticoagulant therapy is often indicated, but risk-benefit assessment is complex.
- Novel endovascular treatments are emerging, necessitating clinical trials for comparison with established therapies.
Abstract:
A heterogeneous group of heart diseases, varying by cardiac anatomy and physiology, are responsible for a variety of embolic materials that result in cerebral and systemic embolism. Atrial fibrillation accounts for nearly half of all cardioembolic stroke, particularly in the elderly, but in the young congenital septal abnormalities such as patent foramen ovale play a more important role. Therapeutic strategies include stabilization or treatment of the underlying heart disease and prevention of embolism. Oral anticoagulant therapy is indicated for many but decision making on balancing the benefits versus risks can be difficult. New endovascular therapies and devices have become available and await clinical trials that allow them to be compared with existing medical therapies.
Related Concept Videos
Cardiovascular Drugs: Classification based on Therapeutic Indications
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Stroke: Introduction and Types
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis IV: Nursing Management
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...